Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02047695
Other study ID # S-20100126
Secondary ID
Status Completed
Phase N/A
First received January 26, 2014
Last updated April 3, 2017
Start date February 2011
Est. completion date April 2017

Study information

Verified date April 2017
Source Odense University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to investigate whether a particular form of migraine, migraine with aura, is associated with structural changes in the brain


Recruitment information / eligibility

Status Completed
Enrollment 345
Est. completion date April 2017
Est. primary completion date April 2015
Accepts healthy volunteers No
Gender Female
Age group 30 Years to 60 Years
Eligibility Inclusion Criteria:

- female

- case (migraine with aura), co-twin to case, or control (migraine-free)

- residency in Denmark

- no severe neurological (vascular, neurodegenerative or neuroinflammatory) disorders, or other somatic or psychiatric disorders

Exclusion Criteria:

- male

- residency outside Denmark

- registered in Civil Registry as not to be contacted by researchers

- severe neurological (vascular, neurodegenerative or neuroinflammatory) disorders, or other somatic or psychiatric disorders

- mobile metal parts or other contraindication for MRI

- weight of 130+ kilograms

- pregnancy

- subjects that wished not to be informed about abnormal findings on MRI

- chronic tension-type headache, medication overuse headache, or cluster headache (diagnosed through physician interview)

- frequent tension-type headache (control group only, self-reported or diagnosed through physician interview)

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
n/a

Sponsors (4)

Lead Sponsor Collaborator
Odense University Hospital Copenhagen University Hospital, Hvidovre, Glostrup University Hospital, Copenhagen, University of Southern Denmark

Outcome

Type Measure Description Time frame Safety issue
Primary Evidence of white matter hyperintensities or subclinical ischaemic stroke confirmed by MRI At time of MRI
Secondary Evidence of other structural and functional changes in brain At time of MRI
See also
  Status Clinical Trial Phase
Completed NCT02253004 - Induction of Migraine Aura With Cilostazol Phase 0
Recruiting NCT02202486 - Investigation of the Blood-brain and Blood-dura Barrier Durin Migraine Attacks Using MRI N/A
Completed NCT00123201 - Study to Evaluate the Efficacy and Safety of Dronabinol Metered Dose Inhaler (MDI) in Acute Treatment of Migraine Headache Phase 2
Completed NCT04406649 - A Study to Evaluate the Safety of STS101 in the Acute Treatment of Migraine Phase 3
Completed NCT03874832 - A Phase I Study to Study the PK and Safety of Single Doses of STS101, DHE Injection and Nasal Spray in Healthy Subjects Phase 1
Recruiting NCT05565001 - The Involvement of ATP Sensitive Potassium Channel in Migraine Aura and Migraine Pain. N/A
Recruiting NCT06459635 - Migraine Attack Pain Phase Prediction Study
Recruiting NCT05416476 - Anisodine Hydrobromide For The Preventive Treatment Of Episodic Migraine Phase 3
Active, not recruiting NCT02906085 - Endothelin-1 as a Potential Trigger of Migraine Aura N/A
Recruiting NCT00893594 - Efficacy of Sumatriptan With Naprosyn in Migraine With Aura N/A
Completed NCT01388699 - Migraine and Endothelial Dysfunction
Completed NCT00534560 - Dose Ranging Study of the Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache Phase 2
Terminated NCT04936061 - Transnasal Cooling for Migraine N/A
Recruiting NCT05281770 - Monoclonal CGRP Antibodies for Migraine Prevention - a Nationwide Real Life Study
Not yet recruiting NCT04063540 - Acid-Sensing Ion Channel and Migraine Disease Proof of Concept Study on the Efficacy of Amiloride in the Prophylaxis of Migraine Aura Phase 2
Completed NCT03472417 - Partial Rebreathing in the Treatment of Migraine With Aura N/A
Completed NCT00334178 - Evaluation of the Efficacy and Safety of Laxymig® as Prophylactic Treatment in Patients With Migraine Phase 3
Recruiting NCT06051604 - Mi-Helper Transnasal Cooling for Acute Treatment of Migraine N/A
Recruiting NCT06414044 - Italian Real-life obServational Study on the effecTiveness, sAfety and Tolerability of Atogepant in Migraine Patients
Completed NCT03472378 - Can DFN-15 Terminate Migraine With Allodynia? Phase 2